Paediatric cancer in low-income and middle-income countries

The Lancet Oncology

Volumn 14, Issue 3, 2013, Pages

  Magrath, Ian ^a,b   Steliarova Foucher, Eva ^c   Epelman, Sidnei ^a   Ribeiro, Raul C ^d   Harif, Mhamed ^e   Li, Chi Kong ^f   Kebudi, Rejin ^g   Macfarlane, Scott D ^h   Howard, Scott C ^d  

^a INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH   (Belgium)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e CENTRE HOSPITALIER UNIVERSITAIRE MOHAMMED VI   (Morocco)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g ISTANBUL UNIVERSITY   (Turkey)

^h STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CAPACITY BUILDING; CHILD HEALTH CARE; CHILDHOOD CANCER; DEVELOPING COUNTRY; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE QUALITY; HUMAN; INFECTION; INTERNATIONAL COOPERATION; MORTALITY; PARASITOSIS; PRIORITY JOURNAL; REVIEW;

CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; HUMANS; NEOPLASMS; PEDIATRICS; RISK FACTORS; WORLD HEALTH;

EID: 84875278765     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70008-1     Document Type: Review

References (95)

1. World development indicators The World Bank, (accessed Jan 31, 2013). http://databank.worldbank.org/data/home.aspx.
2. How we classify countries World Bank, (accessed Dec 12, 2012). http://data.worldbank.org/about/country-classifications.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM GLOBOCAN 2008 v2.0-cancer incidence and mortality worldwide: IARC CancerBase No 10 2010, International Agency for Research on Cancer, Lyon, (accessed Dec 31, 2012). http://globocan.iarc.fr.
4. Global Health Observatory data repository-Cause-specific mortality, 2008: WHO region WHO, (accessed Dec 31, 2012). http://apps.who.int/ghodata/?vid=10012.
5. Parkin DM, Kramárová E, Draper GJ, et al. International incidence of childhood cancer, vol II. IARC Scientific Publications No 144 1998, eds, International Agency for Research on Cancer, Lyon.
6. United Nations Development Programme Human development index (HDI), (accessed Jan 1, 2013). http://hdr.undp.org/en/statistics/hdi/.
7. Valsecchi MG, Steliarova-Foucher E Cancer registration in developing countries: luxury or necessity?. Lancet Oncol 2008, 9:159-167.
8. Aka P, Kawira E, Masalu N, et al. Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr Blood Cancer 2012, 59:1234-1238.
9. Amir H, Kaaya EE, Manji KP, Kwesigabo G, Biberfeld P Kaposi's sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children. Pediatr Infect Dis J 2001, 20:518-521.
10. Howard SC, Metzger ML, Wilimas JA, et al. Childhood cancer epidemiology in low-income countries. Cancer 2008, 112:461-472.
11. Magrath I, Shanta V, Advani S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer 2005, 41:1570-1583.
12. World cancer report 2008 2008, International Agency for Research on Cancer, Lyon. P. Boyle, B. Levin (Eds.).
13. Tukei VJ, Kekitiinwa A, Beasley RP Prevalence and outcome of HIV-associated malignancies among children. AIDS 2011, 25:1789-1793.
14. Ramot B, Magrath I Hypothesis: the environment is a major determinant of the immunological sub-type of lymphoma and acute lymphoblastic leukaemia in children. Br J Haematol 1982, 50:183-189.
15. Court Brown WM, Doll R Leukaemia in childhood and young adult life. BMJ 1961, 1:981-988.
16. Arya LS, Padmanjali KS, Sazawal S, et al. Childhood T-lineage acute lymphoblastic leukemia: management and outcome at a tertiary care center in North India. Indian Pediatr 2011, 48:785-790.
17. Rajalekshmy KR, Abitha AR, Anuratha N, Sagar TG Time trend in frequency of occurrence of major immunophenotypes in paediatric acute lymphoblastic leukemia cases as experienced by Cancer Institute, Chennai, south India during the period 1989-2009. Indian J Cancer 2011, 48:310-315.
18. Hussein H, Sidhom I, Naga SA, et al. Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt. J Pediatr Hematol Oncol 2004, 26:507-514.
19. Kamel AM, Assem MM, Jaffe ES, Magrath I, Aboul Enein MI, Hindawy DS Immunological phenotypic pattern of acute lymphoblastic leukaemia in Egypt. Leuk Res 1989, 13:519-525.
20. Greaves MF Aetiology of acute leukaemia. Lancet 1997, 349:344-349.
21. Rao CR, Gutierrez MI, Bhatia K, et al. Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries. Leuk Lymphoma 2000, 39:329-337.
22. Magrath I Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 2012, 156:744-756.
23. Karajannis MA, Hummel M, Oschlies I, et al. Epstein-Barr virus infection in western European pediatric non-Hodgkin lymphomas. Blood 2003, 102:4244.
24. Rao CR, Franklin J, Lalitha N, et al. Frequency of Epstein Barr virus (EBV) association and p53 expression in childhood and adult Hodgkin's disease in India. Int J Pediatr Hematol Oncol 2000, 6:377-386.
25. Naresh KN, Johnson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 2000, 11:91-96.
26. Rodríguez-Pinilla SM, Barrionuevo C, Garcia J, et al. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from Peru in children and young adults. Am J Surg Pathol 2010, 34:1773-1782.
27. Subramaniam K, D'Rozario J, Pavli P Lymphoma and other lymphoproliferative disorders in IBD: a review. J Gastroenterol Hepatol 2013, 28:24-30.
28. Toumi N, Frikha M, Siala W, et al. Juvenile nasopharyngeal carcinoma: anatomoclinic, biologic, therapeutic and evolutive aspects. Bull Cancer 2010, 97:427-433.
29. Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 2012, 57:730-735.
30. McMahon BJ, Bulkow LR, Singleton RJ, et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 2011, 54:801-807.
31. Mutalima N, Molyneux EM, Johnston WT, et al. Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi-preliminary findings. Infect Agent Cancer 2010, 5:5.
32. Wakeford R Childhood leukaemia following medical diagnostic exposure to ionizing radiation in utero or after birth. Radiat Prot Dosimetry 2008, 132:166-174.
33. Mole RH Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain. Br J Cancer 1990, 62:152-168.
34. Piciu D, Piciu A, Irimie A Thyroid cancer in children: a 20-year study at a Romanian oncology institute. Endocr J 2012, 59:489-496.
35. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 2004, 364:2097-2105.
36. Little MP, Wakeford R, Kendall GM Updated estimates of the proportion of childhood leukaemia incidence in Great Britain that may be caused by natural background ionising radiation. Radiol Prot 2009, 29:467-482.
37. Silbermann M, Al-Hadad S, Ashraf S, et al. MECC regional initiative in pediatric palliative care: Middle Eastern course on pain management. J Pediatr Hematol Oncol 2012, 34(suppl 1):S1-11.
38. The World Health Report 2008: primary health care now more than ever 2008, WHO, World Health Organization, Geneva.
39. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004, 291:2471-2475.
40. WHO model lists of essential medicines-17th edition (March 2011) 2011, WHO, World Health Organization, Geneva.
41. Potterton L Access to affordable radiotherapy. IAEA Bull 2010, 52:10-11.
42. Mwenda AM Uganda: healthcare for the rich. The Independent (Kampala), May 6, 2012 (accessed Feb 8, 2013). http://allafrica.com/stories/201205070746.html.
43. Chatenoud L, Bertuccio P, Bosetti C, Levi F, Negri E, La Vecchia C Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer 2010, 116:5063-5074.
44. Education for sustainable development. Paris: United Nations Educational, Scientific and Cultural Organization UNESCO, (accessed Jan 1, 2013). http://www.unesco.org/new/en/education/themes/leading-the-international-agenda/education-for-sustainable-development/browse/2/.
45. WHO global code of practice on the international recruitment of health personnel. Geneva: World Health Organization WHO, (accessed Dec 31, 2012). http://www.who.int/hrh/en/.
46. Kebudi R Pediatric oncology in Turkey. J Pediatr Hematol Oncol 2012, 34(suppl 1):S12-S14.
47. Health systems financing: the path to universal health coverage-plan of action 2012, WHO, World Health Organization, Geneva.
48. Obalum DC, Fiberesima F Nigerian National Health Insurance Scheme (NHIS): an overview. Niger Postgrad Med J 2012, 19:167-174.
49. Lu C, Chin B, Lewandowski JL, et al. Towards universal health coverage: an evaluation of Rwanda Mutuelles in its first eight years. PLoS One 2012, 7:e39282.
50. Pérez-Cuevas R, Doubova SV, Zapata-Tarres M, et al. Scaling up cancer care for children without medical insurance in developing countries: the case of Mexico. Pediatr Blood Cancer 2013, 60:196-203.
51. Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 2012, 380:1259-1279.
52. Pérez-Cuevas R, Chertorivski S, Cortés-Gallo G, Rodríguez-Ortega E, Caballero F, Muñoz-Hernández O Lessons learned from the first evaluation of the Medical Insurance for a New Generation: bridging research and policy. Salud Publica Mex 2012, 54(suppl 1):S90-S97.
53. Ribeiro RC Impact of the Mexican government's system of social protection for health, or Seguro Popular, on pediatric oncology outcomes. Pediatr Blood Cancer 2012, 60:171-172.
54. Rivera-Luna R, Correa-González C, Altamirano-Alvarez E, et al. Incidence of childhood cancer among Mexican children registered under a public medical insurance program. Int J Cancer 2013, 132:1646-1650.
55. Tang S, Tao J, Bekedam H Controlling cost escalation of healthcare: making universal health coverage sustainable in China. BMC Public Health 2012, 12(suppl 1):S8.
56. Li Y, Wu Q, Xu L, et al. Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance. Bull World Health Organ 2012, 90:664-671.
57. Pritchard-Jones K, Pieters R, Reaman GH, et al. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. Lancet Oncol 2013, published online Feb 20. http://dx.doi.org/10.1016/S1470-2045(13)70010-X.
58. Bhakta N, Martiniuk AL, Gupta S, Howard SC The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi. Arch Dis Child 2013, 98:155-160.
59. Howard SC, Ribeiro RC, Pui CH Strategies to improve outcomes of children with cancer in low-income countries. Eur J Cancer 2005, 41:1584-1587.
60. Epelman S Pediatric oncology in Brazil. Pediatr Hematol Oncol 1998, 15:377-383.
61. Luna-Fineman S, Barnoya M, Bonilla M, Fu L, Baez F, Rodriguez-Galindo C Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA). Pediatr Blood Cancer 2012, 58:545-550.
62. Howard SC, Wilimas JA Delays in diagnosis and treatment of childhood cancer: where in the world are they important?. Pediatr Blood Cancer 2005, 44:303-304.
63. Leander C, Fu LC, Pena A, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007, 49:817-819.
64. Epelman S Preserving vision in retinoblastoma through early detection and intervention. Curr Oncol Rep 2012, 14:213-219.
65. Qaddoumi I, Mansour A, Musharbash A, et al. Impact of telemedicine on pediatric neuro-oncology in a developing country: the Jordanian-Canadian experience. Pediatr Blood Cancer 2007, 48:39-43.
66. Qaddoumi I, Ribeiro RC Can communication technologies reduce inequalities in cancer care?. Lancet Oncol 2011, 12:224.
67. Gavidia R, Fuentes SL, Vasquez R, et al. Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El Salvador. PLoS One 2012, 7:e43639.
68. Gupta N, Seth T, Mishra P, et al. Treatment of acute myeloid leukemia in children: experience from a tertiary care hematology centre in India. Indian J Pediatr 2011, 78:1211-1215.
69. Gupta S, Bonilla M, Valverde P, et al. Treatment-related mortality in children with acute myeloid leukaemia in Central America: incidence, timing and predictors. Eur J Cancer 2012, 48:1363-1369.
70. Raje NS, Rao SR, Iyer RS, et al. Infection analysis in acute lymphoblastic leukemia: a report of 499 consecutive episodes in India. Pediatr Hematol Oncol 1994, 11:271-280.
71. Gupta S, Antillon FA, Bonilla M, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011, 117:4788-4795.
72. Spinetta JJ, Jankovic M, Masera G, et al. Optimal care for the child with cancer: a summary statement from the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Pediatr Blood Cancer 2009, 52:904-907.
73. Ngoma T, Adde M, Durosinmi M, et al. Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease. Br J Haematol 2012, 158:749-762.
74. Somjee S, Pai S, Parikh P, Banavali S, Kelkar R, Advani S Passive active prophylaxis against Hepatitis B in children with acute lymphoblastic leukemia. Leuk Res 2002, 26:989-992.
75. Bakhshi S, Padmanjali KS, Arya LS Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes. Pediatr Hematol Oncol 2008, 25:385-392.
76. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012, 307:1838-1847.
77. Boschmonar MG, Alvarez YG, García AM, Soto TN, Roger MC, Garrote LF Childhood cancer survival in Cuba. Eur J Epidemiol 2000, 16:763-767.
78. Swaminathan R, Rama R, Shanta V Childhood cancers in Chennai, India, 1990-2001: incidence and survival. Int J Cancer 2008, 122:2607-2611.
79. Wiangnon S, Veerakul G, Nuchprayoon I, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev 2011, 12:2215-2220.
80. Bao PP, Zheng Y, Wu CX, et al. Population-based survival for childhood cancer patients diagnosed during 2002-2005 in Shanghai, China. Pediatr Blood Cancer 2012, 59:657-661.
81. Israels T, Moreira C, Scanlan T, et al. SIOP PODC: clinical guidelines for the management of children with Wilms tumour in a low income setting. Pediatr Blood Cancer 2013, 60:5-11.
82. Hesseling P, Israels T, Harif M, Chantada G, Molyneux E Practical recommendations for the management of children with endemic Burkitt Lymphoma (BL) in a resource limited setting. Pediatr Blood Cancer 2012, 60:357-362.
83. Molyneux E, Davidson A, Orem J, et al. The management of children with Kaposi sarcoma in resource limited settings. Pediatr Blood Cancer 2012, published online Dec 19. 10.1002/pbc.24408.
84. Naresh KN, Raphael M, Ayers L, et al. Lymphomas in sub-Saharan Africa-what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?. Br J Haematol 2011, 154:696-703.
85. Gopal S, Wood WA, Lee SJ, et al. Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood 2012, 119:5078-5087.
86. Dunne J, Murphy MD, Rodriguez WJ The globalization of pediatric clinical trials. Pediatrics 2012, 130:e1583-e1591.
87. Lu F, Suda KJ, Marks KE Geographic location of antineoplastic agent clinical trials conducted in developed and developing countries. Int J Clin Pharm 2012, published online Oct 10. 10.1007/s11096-012-9711-6.
88. Salminen E, Izewska J, Andreo P, et al. IAEA's role in the global management of cancer-focus on upgrading radiotherapy services. Acta Oncol 2005, 44:816-824.
89. Perkovic V, Patil V, Wei L, Lv J, Petersen M, Patel A Global randomized trials: the promise of India and China. J Bone Joint Surg Am 2012, 94(suppl 1):92-96.
90. van Litsenburg RR, Uyl-de Groot CA, Raat H, Kaspers GJ, Gemke RJ Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: the influence of new medication and diagnostic technology. Pediatr Blood Cancer 2011, 57:1005-1010.
91. Rahiala J, Riikonen P, Kekäläinen L, Perkkiö M Cost analysis of the treatment of acute childhood lymphocytic leukaemia according to Nordic protocols. Acta Paediatr 2000, 89:482-487.
92. Luo XQ, Ke ZY, Guan XQ, Zhang YC, Huang LB, Zhu J The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China. Pediatr Blood Cancer 2008, 51:204-209.
93. Liu Y, Chen J, Tang J, Ni S, Xue H, Pan C Cost of childhood acute lymphoblastic leukemia care in Shanghai, China. Pediatr Blood Cancer 2009, 53:557-562.
94. Martin G, Grant A, D'Agostino M Global health funding and economic development. Global Health 2012, 8:8.
95. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008, 9:721-729.